4/A//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4/A
Accession 0001062993-17-000505
CIK 0000875622operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:07 PM ET
Size
7.1 KB
Accession
0001062993-17-000505
Insider Transaction Report
Form 4/AAmended
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-11-29$48.32/sh−8,945$432,188→ 292,549 total - Sale
Common Stock, $.001 par value
2016-11-28$48.04/sh−11,055$531,048→ 301,494 total
Footnotes (3)
- [F1]The selling price of $48.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $47.50 to $49.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $48.3161 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.25 to $48.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:07 PM ET
- Size
- 7.1 KB